246 related articles for article (PubMed ID: 31729974)
1. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
Zhao B; Cao K; Li XT; Zhu HT; Sun YS
BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
3. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z
Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
5. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.
Heo SH; Shin SS; Kim JW; Lim HS; Jeong YY; Kang WD; Kim SM; Kang HK
Korean J Radiol; 2013; 14(4):616-25. PubMed ID: 23901319
[TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
Meng J; Zhu L; Zhu L; Wang H; Liu S; Yan J; Liu B; Guan Y; Ge Y; He J; Zhou Z; Yang X
Radiat Oncol; 2016 Oct; 11(1):141. PubMed ID: 27770816
[TBL] [Abstract][Full Text] [Related]
8. Association of Apparent Diffusion Coefficient with Disease Recurrence in Patients with Locally Advanced Cervical Cancer Treated with Radical Chemotherapy and Radiation Therapy.
Gladwish A; Milosevic M; Fyles A; Xie J; Halankar J; Metser U; Jiang H; Becker N; Levin W; Manchul L; Foltz W; Han K
Radiology; 2016 Apr; 279(1):158-66. PubMed ID: 26505922
[TBL] [Abstract][Full Text] [Related]
9. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Erbay G; Guler OC
J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
[TBL] [Abstract][Full Text] [Related]
10. Maximum standardized lymph node uptake value could be an important predictor of recurrence and survival in patients with cervical cancer.
Nakamura K; Joja I; Nagasaka T; Haruma T; Hiramatsu Y
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():77-82. PubMed ID: 24275232
[TBL] [Abstract][Full Text] [Related]
11. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
[TBL] [Abstract][Full Text] [Related]
12. Early alteration in apparent diffusion coefficient and tumor volume in cervical cancer treated with chemoradiotherapy or radiotherapy: Incremental prognostic value over pretreatment assessments.
Watanabe Y; Nakamura S; Ichikawa Y; Ii N; Kawamura T; Kondo E; Ikeda T; Nomoto Y; Sakuma H
Radiother Oncol; 2021 Feb; 155():3-9. PubMed ID: 33039422
[TBL] [Abstract][Full Text] [Related]
13. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
Bae JM; Kim CK; Park JJ; Park BK
Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
[TBL] [Abstract][Full Text] [Related]
14. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
Ho JC; Fang P; Cardenas CE; Mohamed ASR; Fuller CD; Allen PK; Bhosale PR; Frumovitz MM; Jhingran A; Klopp AH
Radiother Oncol; 2019 Jun; 135():58-64. PubMed ID: 31015171
[TBL] [Abstract][Full Text] [Related]
15. Correlation of histogram analysis of apparent diffusion coefficient with uterine cervical pathologic finding.
Lin Y; Li H; Chen Z; Ni P; Zhong Q; Huang H; Sandrasegaran K
AJR Am J Roentgenol; 2015 May; 204(5):1125-31. PubMed ID: 25905952
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
17. Radiomics analysis of apparent diffusion coefficient in cervical cancer: A preliminary study on histological grade evaluation.
Liu Y; Zhang Y; Cheng R; Liu S; Qu F; Yin X; Wang Q; Xiao B; Ye Z
J Magn Reson Imaging; 2019 Jan; 49(1):280-290. PubMed ID: 29761595
[TBL] [Abstract][Full Text] [Related]
18. Histogram analysis of apparent diffusion coefficient maps in the prognosis of patients with locally advanced head and neck squamous cell carcinoma: Comparison of different region of interest selection methods.
Ren JL; Yuan Y; Li XX; Shi YQ; Tao XF
Eur J Radiol; 2018 Sep; 106():7-13. PubMed ID: 30150054
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
20. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
